Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xinxing Feng

Showing results (41-50 of 44) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 44 results.
European Journal of Preventive Cardiology|March 14, 2019
Predictive value of in-hospital white blood cell count in Chinese patients with triple-vessel coronary diseaseXueyan Zhao, Lin Jiang, Lianjun Xu, et al.
Human Gene Therapy|November 10, 2020
Association of <i>NPC1L1</i> and <i>HMGCR</i> Gene Polymorphisms with Major Adverse Cardiac and Cerebrovascular Events in Patients with Three-Vessel DiseaseXueyan Zhao, Jiawen Li, Xiaofang Tang, et al.
Cardiorenal Medicine|October 12, 2023
Mild Renal Function Impairment and Long-Term Outcomes in Patients with Three-Vessel Coronary Artery Disease: A Cohort StudyGuyu Zeng, Deshan Yuan, Peizhi Wang, et al.
Molecular Biology Reports|January 4, 2013
Multiple gene mutations, not the type of mutation, are the modifier of left ventricle hypertrophy in patients with hypertrophic cardiomyopathyYubao Zou, Jizheng Wang, Xuan Liu, et al.
Pageof 5

Showing results (41-50 of 44) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 44 results.
European Journal of Preventive Cardiology|March 14, 2019
Predictive value of in-hospital white blood cell count in Chinese patients with triple-vessel coronary diseaseXueyan Zhao, Lin Jiang, Lianjun Xu, et al.
Human Gene Therapy|November 10, 2020
Association of <i>NPC1L1</i> and <i>HMGCR</i> Gene Polymorphisms with Major Adverse Cardiac and Cerebrovascular Events in Patients with Three-Vessel DiseaseXueyan Zhao, Jiawen Li, Xiaofang Tang, et al.
Cardiorenal Medicine|October 12, 2023
Mild Renal Function Impairment and Long-Term Outcomes in Patients with Three-Vessel Coronary Artery Disease: A Cohort StudyGuyu Zeng, Deshan Yuan, Peizhi Wang, et al.
Molecular Biology Reports|January 4, 2013
Multiple gene mutations, not the type of mutation, are the modifier of left ventricle hypertrophy in patients with hypertrophic cardiomyopathyYubao Zou, Jizheng Wang, Xuan Liu, et al.
Pageof 5